TNFR2 is required for RIP1-dependent cell death in human leukemia.

Saved in:
Bibliographic Details
Title: TNFR2 is required for RIP1-dependent cell death in human leukemia.
Authors: Aguadé-Gorgorió J; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., McComb S; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Eckert C; Department of Pediatric Oncology/Hematology, Charité Medical University Berlin, Berlin, Germany., Guinot A; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Marovca B; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Mezzatesta C; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Jenni S; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Abduli L; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Schrappe M; Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany; and., Dobay MP; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Stanulla M; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany., von Stackelberg A; Department of Pediatric Oncology/Hematology, Charité Medical University Berlin, Berlin, Germany., Cario G; Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany; and., Bourquin JP; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Bornhauser BC; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.
Source: Blood advances [Blood Adv] 2020 Oct 13; Vol. 4 (19), pp. 4823-4833.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2019000796